Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitors.

Likewise, patients who progressed tended to have a higher number of metastatic sites compared with those who discontinued treatment because of toxicity or per protocol, although this did not reach statistical significance.

also in 111,027 other papers